Summary:
Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on a proficiency testing (PT) review and an interview with the laboratory lead, the laboratory failed to rotate the testing of American Association of Bioanalysts (AAB) proficiency testing (PT) samples for complete blood counts (CBCs) by the testing personnel who routinely perform patient testing since the last survey on January 26, 2017. Findings: 1. A review of AAB PT records revealed the laboratory failed to rotate the CBC PT samples by all testing personnel who perform patient testing since the last survey. 2. An interview on October 2, 2018 at 9:35 AM, with the laboratory lead, confirmed the laboratory failed to rotate the CBC proficiency samples from AAB by testing personnel who routinely test patient CBCs since the last survey. D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on a proficiency testing (PT) review, the laboratory failed to successfully participate in proficiency testing for the analyte hematocrit (HCT). Refer to D2130. D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on a proficiency testing (PT) review and the laboratory's graded PT results from the American Association of Bioanalysts (AAB), the laboratory failed to achieve successful performance for the analyte hematocrit (HCT) in two out of three testing events. Findings: Analyte Year Event Score HCT 2018 1 60% HCT 2018 2 0% D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: Based on a record review and an interview with the laboratory lead, the laboratory failed to retain the manufacturer's quality control assay reference sheets for the Horiba Pentra hematology analyzer since the last survey on January 26, 2017. Findings: 1. A review of the quality control records revealed the laboratory failed to retain the manufacturer's Minotrol quality control assay reference sheets since the last survey. 2. An interview on October 2, 2018 at 9:15 AM, with the laboratory lead, confirmed the testing personnel failed to retain the quality control assay sheets for the hematology analyzer. D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: -- 2 of 5 -- Based on a record review of personnel documents and the procedure manual, and an interview with the laboratory lead, the laboratory failed to establish and follow written policies and procedures to evaluate the competency of testing personnel performing complete blood counts since the last survey on January 26, 2017. Findings: 1. A review of competency assessment documents for the testing personnel and a review of the laboratory procedures and policies, revealed the laboratory failed to establish in writing and document the competency evaluations for 6 out of 6 testing personnel listed on the CMS-209 Personnel Report form by a qualified technical consultant. 2. An interview on October 2, 2018 at 9:15 AM, with the laboratory lead, confirmed the laboratory failed to establish and follow written policies and procedures to assess the competency of testing personnel. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)